|
|

Registration to open February 1, 2019

AAADV not only impacts the rate at which oncology drugs are brought to market, but patients afflicted with cancer have been able to appreciate significant advances in their care and survival rates.

Richard Pazdur

Director, Oncology Center of Excellence

U.S. Food and Drug Administration Center for Drug Evaluation and Research

Programs

16th Annual AAADV Workshop

Leaders in clinical and translational cancer research from academic, industry, government and the nonprofit advocacy sector focus on understanding and efficiently negotiating the drug development process.

May 8-10, 2019

Enroll Now

 


Download AAADV Mobile app for Android and iOS

google -play-image apple-store-image


Message from the Program Chair

Speakers

 

Location